Takeda denies deliberate use of crafty tactics
By changing the product number of medicine packages, companies are able to turn up the price without running any risks. But it is purely coincidental that Takeda’s change in product numbers coincides with a price increase of up to 1308 %, the company explains.
by Leonora Beck
Takeda Denmark is in the process of changing the product numbers on its medicine packages. The reason is that the Japanese parent company acquired Nycomed in 2011 and is now in the process of changing the company name on the packages to Takeda Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
